InspireMD: Rises on positive data from carotid artery disease study
10/06/2020 15:40
** Medical device developer's shares NSPR.N rise 22.7% to
69 cents
** Company says results from a 12-month study shows its
stent, CGuard EPS, to treat carotid stenosis delivered
protection against post-procedural neurologic events
urn:newsml:reuters.com:*:nGNX4NrNkt
** Carotid stenosis is the narrowing of carotid arteries,
caused by a buildup of plaque inside the artery wall that
reduces blood flow to the brain
** NSPR says study results show that no strokes occurred
between 30 days and twelve months
** Stock down 36% this year
(Reporting by Dania Nadeem in Bengaluru)
((mailto:dania.nadeem@thomsonreuters.com))